Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11

Trial Status

Other1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT06149260Phase 1Unknown
Subcutaneous Semaglutide in Systemic Scleroderma
FibrosisScleroderma, SystemicSemaglutide
PrincipalinvestigatorStart date: 2024-02-29

Research Network

Collaboration Network

11 collaborators·50 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Second Xiangya Hospital

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Ruixuan Zhu, MD

Second Xiangya Hospital

Moderately Similar
1 trials

Shared therapeutic areas:

FibrosisScleroderma, SystemicSemaglutide

Worked with same sponsors:

Second Xiangya Hospital of Central South University
Collaborated on 1 trial
Similarity Score34%

Xiangning Qiu, MD

Second Xiangya Hospital

Moderately Similar
1 trials

Shared therapeutic areas:

FibrosisScleroderma, SystemicSemaglutide

Worked with same sponsors:

Second Xiangya Hospital of Central South University
Collaborated on 1 trial
Similarity Score34%

Zhan Yi, MD

Second Xiangya Hospital

Moderately Similar
1 trials

Shared therapeutic areas:

FibrosisScleroderma, SystemicSemaglutide

Worked with same sponsors:

Second Xiangya Hospital of Central South University
Collaborated on 1 trial
Similarity Score34%

Hao Ren, MD

Second Xiangya Hospital

Moderately Similar
1 trials

Shared therapeutic areas:

FibrosisScleroderma, SystemicSemaglutide

Worked with same sponsors:

Second Xiangya Hospital of Central South University
Collaborated on 1 trial
Similarity Score34%

Rong Xiao, MD

Department of Dermatology, Second Xiangya Hospital of Central South University, Changsha, China

Moderately Similar
1 trials

Shared therapeutic areas:

FibrosisScleroderma, SystemicSemaglutide

Worked with same sponsors:

Second Xiangya Hospital of Central South University
Collaborated on 1 trial
Similarity Score34%

Zhuotong Zeng, MD

Second Xiangya Hospital

Moderately Similar
1 trials

Shared therapeutic areas:

FibrosisScleroderma, SystemicSemaglutide

Worked with same sponsors:

Second Xiangya Hospital of Central South University
Collaborated on 1 trial
Similarity Score34%

Yi Wei, MD

Second Xiangya Hospital

Moderately Similar
1 trials

Shared therapeutic areas:

FibrosisScleroderma, SystemicSemaglutide

Worked with same sponsors:

Second Xiangya Hospital of Central South University
Collaborated on 1 trial
Similarity Score34%

Yangfan Xiao, MD

Second Xiangya Hospital

Moderately Similar
1 trials

Shared therapeutic areas:

FibrosisScleroderma, SystemicSemaglutide

Worked with same sponsors:

Second Xiangya Hospital of Central South University
Collaborated on 1 trial
Similarity Score34%

Ke Chai, MD

Second Xiangya Hospital

Moderately Similar
1 trials

Shared therapeutic areas:

FibrosisScleroderma, SystemicSemaglutide

Worked with same sponsors:

Second Xiangya Hospital of Central South University
Collaborated on 1 trial
Similarity Score34%

Licong Liu, MD

Second Xiangya Hospital

Moderately Similar
1 trials

Shared therapeutic areas:

FibrosisScleroderma, SystemicSemaglutide

Worked with same sponsors:

Second Xiangya Hospital of Central South University
Collaborated on 1 trial
Similarity Score34%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT06149260Phase 1PrincipalInvestigator

Subcutaneous Semaglutide in Systemic Scleroderma

FibrosisScleroderma, SystemicSemaglutide
Unknown

All 1 trials loaded